Rectally Administrated Thioguanine for Distal Ulcerative Colitis: A Multicenter Case Series.
作者信息
Crouwel Femke, Simsek Melek, van Doorn Amarylle S, Mulder Chris J J, Buiter Hans J C, Barclay Murray L, Florin Timothy H, de Boer Nanne K
机构信息
Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Departments of Gastroenterology & Clinical Pharmacology, Christchurch Hospital, Canterbury District Health Board and University of Otago, Christchurch, New Zealand.
出版信息
Inflamm Bowel Dis. 2023 Jun 1;29(6):1000-1004. doi: 10.1093/ibd/izac195.
Abstract
摘要
相似文献
1
Rectally Administrated Thioguanine for Distal Ulcerative Colitis: A Multicenter Case Series.直肠给药硫鸟嘌呤治疗远端溃疡性结肠炎：一项多中心病例系列研究
Inflamm Bowel Dis. 2023 Jun 1;29(6):1000-1004. doi: 10.1093/ibd/izac195.
2
Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis.在溃疡性结肠炎的治疗中，硫鸟嘌呤的长期治疗耐受性良好且安全。
Dig Liver Dis. 2011 Feb;43(2):110-5. doi: 10.1016/j.dld.2010.07.004. Epub 2010 Aug 24.
3
[Pancytopenia associated with thioguanine use].[与硫鸟嘌呤使用相关的全血细胞减少症]
Ned Tijdschr Geneeskd. 2018 Oct 18;162:D2839.
4
Variceal hemorrhage in a patient with ulcerative colitis treated with 6-Thioguanine.一名接受6-硫鸟嘌呤治疗的溃疡性结肠炎患者发生静脉曲张出血。
Inflamm Bowel Dis. 2008 Apr;14(4):582-3. doi: 10.1002/ibd.20323.
5
Is there a role for thioguanine therapy in IBD in 2017 and beyond?2017年及以后，硫鸟嘌呤疗法在炎症性肠病中是否有作用？
Expert Rev Gastroenterol Hepatol. 2017 May;11(5):473-486. doi: 10.1080/17474124.2017.1294062. Epub 2017 Feb 20.
6
Is the dose of thioguanine the key to better safety profile?硫鸟嘌呤的剂量是改善安全性的关键吗？
Dig Liver Dis. 2011 Feb;43(2):96-7. doi: 10.1016/j.dld.2010.11.003. Epub 2010 Dec 14.
7
MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.6-硫鸟嘌呤相关肝窦阻塞综合征一例的MRI表现
Am J Gastroenterol. 2016 Jun;111(6):767. doi: 10.1038/ajg.2016.210.
8
Low and adequately dosed 6-thioguanine: not so bad after all.低剂量且剂量合适的6-硫鸟嘌呤：终究没那么糟糕。
Inflamm Bowel Dis. 2008 Aug;14(8):1166-7. doi: 10.1002/ibd.20437.
9
Patient-Reported Experiences with a Relicensed Generic: Thioguanine for the Treatment of Inflammatory Bowel Diseases.患者报告的再许可仿制药使用体验：硫鸟嘌呤治疗炎症性肠病
J Gastrointestin Liver Dis. 2018 Dec;27(4):385-389. doi: 10.15403/jgld.2014.1121.274.tor.
10
Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.直肠用5-氨基水杨酸的定位：在远端溃疡性结肠炎中的作用
Am J Gastroenterol. 2000 Jul;95(7):1628-36. doi: 10.1111/j.1572-0241.2000.02180.x.
引用本文的文献
1
Personalized medicine to implementation science: Thiopurines set for the leap.从个性化医疗到实施科学：硫嘌呤即将实现飞跃。
JGH Open. 2022 Oct 17;6(10):651-657. doi: 10.1002/jgh3.12829. eCollection 2022 Oct.
本文引用的文献
1
Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis.患者对氨基水杨酸酯类药物治疗溃疡性结肠炎的偏好与依从性
Clin Exp Gastroenterol. 2021 Aug 29;14:343-351. doi: 10.2147/CEG.S237653. eCollection 2021.
2
Thioguanine Therapy in Inflammatory Bowel Diseases. A Practical Guide.巯嘌呤在炎症性肠病中的治疗。实用指南。
J Gastrointestin Liver Dis. 2020 Dec 13;29(4):637-645. doi: 10.15403/jgld-2765.
3
Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review.硫鸟嘌呤治疗炎症性肠病的疗效：一项系统评价。
World J Gastroenterol. 2016 Oct 28;22(40):9012-9021. doi: 10.3748/wjg.v22.i40.9012.
4
Microbiota: relevant player in thiopurine metabolisation?微生物群：硫嘌呤代谢中的相关参与者？
Gut. 2017 Jan;66(1):1-3. doi: 10.1136/gutjnl-2016-312450. Epub 2016 Aug 24.
5
Microbial metabolism of thiopurines: A method to measure thioguanine nucleotides.硫嘌呤的微生物代谢：一种测量硫鸟嘌呤核苷酸的方法。
J Microbiol Methods. 2016 Sep;128:102-107. doi: 10.1016/j.mimet.2016.07.017. Epub 2016 Jul 19.
6
Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism.结肠微生物群可通过硫鸟嘌呤独立于T淋巴细胞和宿主代谢促进小鼠结肠炎的快速局部改善。
Gut. 2017 Jan;66(1):59-69. doi: 10.1136/gutjnl-2015-310874. Epub 2016 Jul 13.
7
Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease.综述文章：炎症性肠病中美沙拉嗪治疗的药物遗传学和药代动力学的最新进展。
Aliment Pharmacol Ther. 2016 Apr;43(8):863-883. doi: 10.1111/apt.13559. Epub 2016 Feb 14.
8
Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease.抑制 p21Rac 信号和增强固有免疫可介导克罗恩病缓解。
Sci Transl Med. 2014 Apr 23;6(233):233ra53. doi: 10.1126/scitranslmed.3006763.
9
Inhibition of GTPase Rac1 in endothelium by 6-mercaptopurine results in immunosuppression in nonimmune cells: new target for an old drug.6-巯基嘌呤抑制内皮细胞中的 GTPase Rac1 导致非免疫细胞免疫抑制：老药新靶点。
J Immunol. 2014 May 1;192(9):4370-8. doi: 10.4049/jimmunol.1302527. Epub 2014 Mar 26.
10
Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines.早期效应功能的保留随后是最终T细胞记忆的耗竭：硫嘌呤类药物效应延迟出现的一种模型。
Gut. 2009 Mar;58(3):396-403. doi: 10.1136/gut.2008.157339. Epub 2008 Oct 2.
Zotero 插件